Omnimmune Holdings, Inc.
OMMH · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $225 | $0 | $0 | $0 |
| SG&A Expenses | $225 | $450 | $264 | $399 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $225 | $450 | $264 | $399 |
| Operating Income | -$225 | -$450 | -$264 | -$399 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$79 | $422 | -$738 | $399 |
| Pre-Tax Income | -$303 | -$28 | -$1,001 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$303 | -$28 | -$1,001 | -$462 |
| % Margin | – | – | – | – |
| EPS | -0.03 | -0.003 | -0.11 | -0.052 |
| % Growth | -867.7% | 97.2% | -111.6% | – |
| EPS Diluted | -0.03 | -0.003 | -0.11 | -0.052 |
| Weighted Avg Shares Out | 9,231 | 8,915 | 8,915 | 8,879 |
| Weighted Avg Shares Out Dil | 9,231 | 8,915 | 8,915 | 8,879 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $79 | $75 | $232 | $63 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$225 | $47 | -$769 | -$399 |
| % Margin | – | – | – | – |